ICON Public Limited Company
ICLR
Kedudukan dalam Saham
#1601
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Harga Saham
$174.64
Modal Pasaran
$13.47B
Perubahan (1 hari)
3.87%
Perubahan (1 tahun)
-7.33%
Negara
IE
Perdagangan ICON Public Limited Company (ICLR)
Kategori
Healthcare
Nisbah P/E bagi ICON Public Limited Company (ICLR)
Nisbah P/E pada October 2026 TTM: 39.38
Menurut laporan kewangan dan harga saham terkini ICON Public Limited Company, nisbah P/E semasa (TTM) ialah 39.38. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 37.95.
Sejarah nisbah P/E bagi ICON Public Limited Company dari 2001 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 39.38 | 80.24% |
| 2024 | 21.85 | -42.42% |
| 2023 | 37.95 | 21.09% |
| 2022 | 31.34 | -76.90% |
| 2021 | 135.68 | 331.54% |
| 2020 | 31.44 | 26.76% |
| 2019 | 24.80 | 14.51% |
| 2018 | 21.66 | -1.60% |
| 2017 | 22.01 | 38.92% |
| 2016 | 15.85 | -16.84% |
| 2015 | 19.06 | 4.81% |
| 2014 | 18.18 | -24.06% |
| 2013 | 23.94 | -20.29% |
| 2012 | 30.04 | -33.47% |
| 2011 | 45.15 | 200.61% |
| 2010 | 15.02 | 11.16% |
| 2009 | 13.51 | -7.96% |
| 2008 | 14.68 | -7.47% |
| 2007 | 15.87 | 13.86% |
| 2006 | 13.93 | -38.57% |
| 2005 | 22.68 | 356.33% |
| 2004 | 4.97 | 12.27% |
| 2003 | 4.43 | -18.73% |
| 2002 | 5.45 | -20.05% |
| 2001 | 6.81 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 36.15 | -8.20% |
US
|
|
| 39.77 | 0.99% |
US
|
|
| -290.26 | -837.01% |
US
|
|
| - | - |
CN
|
|
| 34.18 | -13.20% |
US
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.